Samantha O. Hasenleithner

Medical University of Graz

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Cancer Biology Cancer Biology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Catherine Alix-Panabières

Associate Professor, Director

University Hospital of Montpellier

FRANCE

View details

Ellen Heitzer

Full Professor

Medical University of Graz

AUSTRIA

View details

Gerald Hoefler

Professor for Pathology

Medical University of Graz

AUSTRIA

View details

Francesco Gatto

Karolinska Institutet

SWEDEN

View details

Sinead Toomey

Royal College of Surgeons in Ireland

IRELAND

View details

Michael R Speicher

Medical University of Graz

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samantha O. Hasenleithner

Research Interests

Explore related searches

Contact this professor

Articles (12)

Clinical applications of next‐generation sequencing‐based <scp>ctDNA</scp> analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Liquid profiling for patients with advanced cancer is ready for clinical integration

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring

How to detect cancer early using cell-free DNA.

A clinician's handbook for using ctDNA throughout the patient journey.

Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.

Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.

Collaborators (6)

Catherine Alix-Panabières

Ellen Heitzer

Gerald Hoefler

Francesco Gatto

Sinead Toomey

Michael R Speicher

Make your next move.